KKM Financial LLC Has $2.35 Million Position in CME Group Inc. (NASDAQ:CME)

KKM Financial LLC increased its position in CME Group Inc. (NASDAQ:CME) by 7.0% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 10,630 shares of the financial services provider’s stock after acquiring an additional 695 shares during the quarter. KKM Financial LLC’s holdings in CME Group were worth $2,346,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in CME. CreativeOne Wealth LLC acquired a new stake in CME Group during the 1st quarter valued at approximately $315,000. Keeley Teton Advisors LLC increased its position in CME Group by 93.6% during the 1st quarter. Keeley Teton Advisors LLC now owns 2,275 shares of the financial services provider’s stock valued at $490,000 after purchasing an additional 1,100 shares during the period. LRI Investments LLC bought a new position in shares of CME Group during the 1st quarter worth approximately $100,000. Epoch Investment Partners Inc. boosted its holdings in shares of CME Group by 4.7% during the 1st quarter. Epoch Investment Partners Inc. now owns 99,947 shares of the financial services provider’s stock worth $21,518,000 after buying an additional 4,454 shares in the last quarter. Finally, Magnetar Financial LLC bought a new position in shares of CME Group during the 1st quarter worth approximately $2,051,000. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Activity

In other news, CFO Lynne Fitzpatrick sold 754 shares of the firm’s stock in a transaction on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total transaction of $163,610.46. Following the completion of the sale, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at $2,877,504.39. This trade represents a 5.38 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Bryan T. Durkin sold 7,593 shares of CME Group stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the sale, the director now directly owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. This trade represents a 12.01 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 15,621 shares of company stock valued at $3,441,063 in the last ninety days. 0.30% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

CME has been the topic of a number of research analyst reports. Redburn Atlantic cut CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price target on the stock. in a report on Tuesday, October 8th. Royal Bank of Canada restated a “sector perform” rating and set a $235.00 price target on shares of CME Group in a report on Thursday, October 24th. Piper Sandler increased their price target on CME Group from $240.00 to $250.00 and gave the stock an “overweight” rating in a report on Monday, October 28th. The Goldman Sachs Group increased their price target on CME Group from $195.00 to $198.00 and gave the stock a “sell” rating in a report on Thursday, October 3rd. Finally, Oppenheimer increased their price target on CME Group from $245.00 to $258.00 and gave the stock an “outperform” rating in a report on Thursday, October 24th. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $224.47.

CME Group Price Performance

Shares of NASDAQ:CME opened at $229.04 on Friday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.09. The stock’s fifty day simple moving average is $223.64 and its two-hundred day simple moving average is $211.07. CME Group Inc. has a 1-year low of $190.70 and a 1-year high of $230.74. The stock has a market cap of $82.54 billion, a PE ratio of 24.08, a price-to-earnings-growth ratio of 5.23 and a beta of 0.55.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, beating the consensus estimate of $2.65 by $0.03. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The business had revenue of $1.58 billion for the quarter, compared to analysts’ expectations of $1.59 billion. During the same period last year, the business earned $2.25 EPS. The business’s revenue was up 18.4% on a year-over-year basis. As a group, analysts forecast that CME Group Inc. will post 10.22 EPS for the current fiscal year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Monday, December 9th will be given a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a dividend yield of 2.01%. The ex-dividend date of this dividend is Monday, December 9th. CME Group’s dividend payout ratio is presently 48.37%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.